有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | [(2R)-1-(1-adamantyl)-1-oxopropan-2-yl] 3-(4,6-dimethyl-2-methylsulfanylpyrimidin-5-yl)propanoate | —— | C23H32N2O3S |
|
—— | propan-2-yl (2E,5R)-5-(4-methoxyphenyl)-7-methyl-2-[(3-nitro-4-pyrimidin-2-ylsulfanylphenyl)methylidene]-3-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate | —— | C29H25N5O6S2 |
|
—— | 2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-methyl-N-[(1S)-1-phenylethyl]acetamide | —— | C24H29N5O2S |
|
—— | [(1S)-1-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)ethyl] 2-(4-chlorophenyl)sulfanylacetate | —— | C16H13ClN2O3S2 |
|
—— | [(1R)-1-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)ethyl] 2-(4-chlorophenyl)sulfanylacetate | —— | C16H13ClN2O3S2 |
|
—— | (2R)-2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-cyclohexyl-N-methylpropanamide | —— | C23H33N5O2S |
|
—— | (2S)-2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1R)-1-(4-fluorophenyl)ethyl]propanamide | —— | C24H28FN5O2S |
|
—— | (2S)-2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-cyclohexyl-N-methylpropanamide | —— | C23H33N5O2S |
|
—— | (2R)-2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1S)-1-(4-fluorophenyl)ethyl]propanamide | —— | C24H28FN5O2S |
|
—— | (2S)-2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1S)-1-(4-fluorophenyl)ethyl]propanamide | —— | C24H28FN5O2S |
|
—— | 2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-methyl-N-[(1R)-1-phenylethyl]acetamide | —— | C24H29N5O2S |
|
—— | (2R)-2-[(4-benzyl-5-morpholin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1R)-1-(4-fluorophenyl)ethyl]propanamide | —— | C24H28FN5O2S |
|
—— | (2R)-2-[[4-(2-methylpropyl)-5-morpholin-4-yl-1,2,4-triazol-3-yl]sulfanyl]-N-[(1S)-1-phenylethyl]propanamide | —— | C21H31N5O2S |
|
—— | (2R)-2-[[4-(2-methylpropyl)-5-morpholin-4-yl-1,2,4-triazol-3-yl]sulfanyl]-N-[(1R)-1-phenylethyl]propanamide | —— | C21H31N5O2S |
|
—— | (2S)-2-[[4-(2-methylpropyl)-5-morpholin-4-yl-1,2,4-triazol-3-yl]sulfanyl]-N-[(1S)-1-phenylethyl]propanamide | —— | C21H31N5O2S |
|
—— | (2S)-2-[[4-(2-methylpropyl)-5-morpholin-4-yl-1,2,4-triazol-3-yl]sulfanyl]-N-[(1R)-1-phenylethyl]propanamide | —— | C21H31N5O2S |
|
—— | (2S)-N-[(1R)-1-(4-fluorophenyl)ethyl]-2-[[4-(2-methylpropyl)-5-morpholin-4-yl-1,2,4-triazol-3-yl]sulfanyl]propanamide | —— | C21H30FN5O2S |
|
—— | (2S)-N-[(1S)-1-(4-fluorophenyl)ethyl]-2-[[4-(2-methylpropyl)-5-morpholin-4-yl-1,2,4-triazol-3-yl]sulfanyl]propanamide | —— | C21H30FN5O2S |
|
—— | (2R)-N-[(1S)-1-(4-fluorophenyl)ethyl]-2-[[4-(2-methylpropyl)-5-morpholin-4-yl-1,2,4-triazol-3-yl]sulfanyl]propanamide | —— | C21H30FN5O2S |
|
—— | (2R)-N-[(1R)-1-(4-fluorophenyl)ethyl]-2-[[4-(2-methylpropyl)-5-morpholin-4-yl-1,2,4-triazol-3-yl]sulfanyl]propanamide | —— | C21H30FN5O2S |
|
—— | 2-[(1R)-1-[[5-cyclopropyl-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-5-thiophen-2-yl-1,3,4-oxadiazole | —— | C18H17N5O2S2 |
|
—— | 3-(2,4-Dinitrophenyl)sulfanyl-4-methyl-1,2,4-triazole | —— | C9H7N5O4S |
|
—— | 2-[(1R)-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)ethyl]-5-thiophen-2-yl-1,3,4-oxadiazole | —— | C17H16N2O3S2 |
|
—— | N-(2-methoxyethyl)-5-[(1S)-1-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]ethyl]sulfanyl-1,3,4-thiadiazol-2-amine | —— | C16H19N5O2S2 |
|
—— | 4-(3-methoxypropyl)-3-[(1S)-1-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]ethyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C17H21N5O3S |
|
—— | N-(2-methoxyethyl)-5-[(1R)-1-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]ethyl]sulfanyl-1,3,4-thiadiazol-2-amine | —— | C16H19N5O2S2 |
|
—— | 2-[(1R)-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)ethyl]-5-(4-methylphenyl)-1,3,4-oxadiazole | —— | C20H20N2O3S |
|
—— | 4-(3-methoxypropyl)-3-[(1R)-1-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]ethyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C17H21N5O3S |
|
—— | (5R,7R)-3-(4-methylphenyl)-N-[3-[4-(2-methylpropyl)-5-methylsulfanyl-1,2,4-triazol-3-yl]propyl]adamantane-1-carboxamide | —— | C28H40N4OS |
|
—— | N-[(1S)-1-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2-methylpropyl]-2-(2-methylphenyl)sulfanylacetamide | —— | C22H27NO3S |
|
—— | 2-[(1S)-1-[(5-butylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]ethyl]-5-(4-methylphenyl)-1,3,4-oxadiazole | —— | C17H20N4OS3 |
|
—— | 2-[(1R)-1-[(5-butylsulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]ethyl]-5-(4-methylphenyl)-1,3,4-oxadiazole | —— | C17H20N4OS3 |
|
—— | N-cyclopropyl-N-[(3R)-1,1-dioxothiolan-3-yl]-2-[5-(trifluoromethyl)pyridin-2-yl]sulfanylacetamide | —— | C15H17F3N2O3S2 |
|
—— | (5S,7R)-3-(4-methylphenyl)-N-[3-[4-(2-methylpropyl)-5-methylsulfanyl-1,2,4-triazol-3-yl]propyl]adamantane-1-carboxamide | —— | C28H40N4OS |
|
—— | N-cyclopropyl-N-[(3S)-1,1-dioxothiolan-3-yl]-2-[5-(trifluoromethyl)pyridin-2-yl]sulfanylacetamide | —— | C15H17F3N2O3S2 |
|
—— | [(2S)-1-(dimethylamino)-1-oxopropan-2-yl] 2-(4-bromo-2,5-dimethylphenyl)sulfanylacetate | —— | C15H20BrNO3S |
|
—— | (Z)-3-(5-methylfuran-2-yl)-N-[3-[4-(2-methylpropyl)-5-methylsulfanyl-1,2,4-triazol-3-yl]propyl]prop-2-enamide | —— | C18H26N4O2S |
|
—— | [(2R)-1-(dimethylamino)-1-oxopropan-2-yl] 2-(4-bromo-2,5-dimethylphenyl)sulfanylacetate | —— | C15H20BrNO3S |
|
—— | (E)-3-(5-methylfuran-2-yl)-N-[3-[4-(2-methylpropyl)-5-methylsulfanyl-1,2,4-triazol-3-yl]propyl]prop-2-enamide | —— | C18H26N4O2S |
|
—— | N-cyclopentyl-N-[(3S)-1,1-dioxothiolan-3-yl]-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C17H26N4O3S2 |
|
—— | N-[(S)-phenyl(thiophen-2-yl)methyl]-2-pyridin-2-ylsulfanylacetamide | —— | C18H16N2OS2 |
|
—— | N-[4-(2-methylbutan-2-yl)cyclohexyl]-2-pyridin-2-ylsulfanylacetamide | —— | C18H28N2OS |
|
—— | N-cyclopentyl-N-[(3R)-1,1-dioxothiolan-3-yl]-2-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]acetamide | —— | C17H26N4O3S2 |
|
—— | 4-cyclopropyl-3-[2-[(2R,6R)-2,6-dimethylmorpholin-4-yl]-2-oxoethyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C13H20N4O3S |
|
—— | 4-cyclopropyl-3-[(1S)-2-oxocyclohexyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C11H15N3O2S |
|
—— | N-(3-phenylsulfanylpropyl)-2-pyridin-2-ylsulfanylacetamide | —— | C16H18N2OS2 |
|
—— | N-[(2S)-5-methylhexan-2-yl]-2-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C18H25N3O2S |
|
—— | 2-(2-Methylphenyl)-5-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-1,3,4-oxadiazole | —— | C19H16N4O2S |
|
—— | N-[(1R)-1-cyclopropylethyl]-2-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C16H19N3O2S |
|
—— | N-[4-(2-methylbutan-2-yl)cyclohexyl]-2-[[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C22H31N3O2S |
|